The macula is found at the center of the retina where the incoming rays of light are focused. The macula is responsible for what we see straight in front of us, for the detailed vision needed in activities such as reading and writing, for recognizing faces, and our ability to appreciate color.
Macular Degeneration is a condition in which the delicate cells of the macula become damaged and stop working. Vision loss usually occurs gradually and typically affects both eyes at different rates.
The "dry" form makes up around 70% of cases: the visual cells simply cease to function, like the colors fading in an old photograph. The process involves thinning of the macular tissues and disturbances in its pigmentation.
The "wet" form makes up the remaining 30% of cases and can involve bleeding within and beneath the retina, opaque deposits, and eventually scar tissue. The "wet" form accounts for 90% of all cases of legal blindness amongst macular degeneration patients.
The dry form will often begin to convert to wet, with the formation of abnormal choroidal blood vessels – angiogenesis. The reason why angiogenesis occurs is unknown but it is believed that this additional blood vessel development is somehow caused by deposits being left in the back of the eye. These deposits are similar to age spots on the skin. These new blood vessels are fragile and have a propensity to leak and bleed, eventually forming scar tissue and resulting in irreversible vision loss.
Studies of twins indicate that both genetic and non-genetic factors play important roles in age-related macular degeneration. If several members of a family are sufferers then it is very important that other members have their eyes checked regularly. Inherited macular degeneration is known as macular dystrophy.
Any type of smoking or exposure to tobacco smoke can accelerate the development of the "wet" type of macular degeneration.
The formation of new blood vessels and yellow deposits ("drusen") in and under the macula is often the first physical sign that macular degeneration may develop.
In the early stages, central vision becomes blurred or distorted, with objects having an unusual size or shape. This may happen quickly or develop over several months. The patient may be very sensitive to light or actually see lights that are not there.
Those with the advanced condition will often notice a blank patch or dark spot in the center of their sight. This makes activities like reading, writing, driving and recognizing small objects or faces very difficult.
The following are NOT known to be linked to macular degeneration: floaters (moving spots caused by debris floating in the vitreous fluid between the lens and the retina); dry eye syndromes; cataracts and cataract surgery.
Peripheral vision (side vision) isn't affected by macular degeneration.
Some cases of age-related macular degeneration are detected early during a routine eye test. It will often be suspected in those aged over 60 who are experiencing changes in their central vision.
The following tests may be performed:
Early detection is important because a patient destined to develop macular degeneration can sometimes be treated before symptoms appear and this may delay or reduce the severity of the disease. Furthermore, as we develop better treatments for macular degeneration, whether they are medicinal, surgical, or low vision aids, those patients diagnosed with macular degeneration can sooner benefit from them.
At this time there is no known cure for macular degeneration. There are ways to slow macular degeneration, depending on the type and the degree of the condition. Current treatments fall into three main categories:
Surgery. Laser surgery to remove the scar produced by macular degeneration has been successful in about 10% of people with disciform degeneration, mainly the younger patients. If the degeneration is associated with leaking blood vessels in the center of the macula and vision is worse than 20⁄70 then laser surgery called photocoagulation is recommended. This will not improve vision but generally reduces further vision loss. Unfortunately for most people, the area of degeneration is in the middle of the macula, at its focal point. This means that treatment cannot be given because the scars produced by the laser would make central vision worse rather than better. 'Dry' degeneration cannot be treated by laser.
Special sunglasses that block out the blue end of the spectrum may decrease the progress of the disease. It has been demonstrated that the blue rays of the light spectrum seem to accelerate macular degeneration more than the others. This means that very bright light, such as sunlight or its reflection in the ocean and desert, may worsen macular degeneration.
Although the medications used to treat hypertension have not been shown to have any direct effect on macular degeneration, they may slow progression of the disease by reducing hypertension. Hypertension tends to make some forms of macular degeneration worse, particularly in the "wet" form where the retinal tissues are invaded by new blood vessels.
There is some good news: macular degeneration is not painful, and never leads to total blindness. It is the most common cause of poor sight in people over 60 but never leads to complete sight loss because it is only the central vision that is affected. Macular degeneration never affects vision at the outer edges of the eye, so most sufferers will have enough side vision to get around and keep their independence.
The bad news is that if you have macular degeneration in one eye then it will usually develop in the other also. In the early stages, only one eye may be affected, but as the disease progresses, both eyes are usually affected. Even with a loss of central vision, however, color vision and peripheral vision may remain clear.
In some cases, macular degeneration may be active and then slow down considerably, or even stop progressing for many years.
The following signs may be indicative of macular problems and anyone experiencing these symptoms should consult an ophthalmologist immediately:
In the early stages, central vision may be blurred or distorted, with things looking an unusual size or shape. This may happen quickly or develop over several months.
Any type of smoking or exposure to tobacco smoke can accelerate the development of the 'wet' type of macular degeneration. Smokers on average exhibit only half the density of yellow macular pigment (lutein and zeaxanthin) and develop macular degeneration 7 years sooner than non-smokers.
Children and young people can suffer from an inherited form of macular degeneration called macular dystrophy. Sometimes several members of a family will suffer from this, and if this is the case in your family it is very important that you have your eyes checked regularly.
A study published in October 2011 and involving 4,000 elderly participants across Europe found that those who took aspirin every day were twice as likely to be diagnosed with late stage age-related macular degeneration (AMD) as those who did not.
NOTE: For those suffering from heart disease, the benefits of taking aspirin outweigh the risks posed to their vision.
During another major study at the Netherlands Institute for Neuroscience and Academic Medical Centre, researchers followed 839 people and found that among those who took aspirin each day, around 4% had an advanced form of the disease called neovascular or 'wet' AMD, which leads to the most profound blindness. In comparison, just 2% who took aspirin less frequently had the same disease.
A more conclusive Australian study was published January 2013 in the Journal of the American Medical Association (JAMA) and followed 2,400 subjects for 15 years. It found that 3.7% of the 'occasional' users of aspirin and 9.4% of the 'regular' users developed wet AMD.
Researchers have found that age-related macular degeneration correlates with low glutathione levels. When taking into consideration other variables such as smoking, age, cardiovascular disease and multivitamin use, depletion of glutathione by itself was thought to be a major contributing factor behind macular degeneration. [British Journal of Ophthalmology, 1994; 78 , pp.791-4)]
Bindweed prevents new vessel growth and may help stop the scarring and permanent damage seen with wet macular degeneration. The suggested dose is two 250mg capsules per day.
Ginkgo Biloba appears to reduce the risk of macular degeneration. [Recent Results in Pharmacology and Clinic, Fuenfgeld FW, ed. Berlin: Springer-Verlag, 1988; pp.231-6]
There is evidence that eating fresh fruits and dark green, leafy vegetables (such as spinach and collard greens) may delay or reduce the severity of age-related macular degeneration.
Oral use of zinc has produced improvement in vision. Intravenous administration along with selenium have demonstrated benefits in the treatment of macular degeneration. According to researchers at Harvard University, however, zinc has shown mixed results. [Arch Ophthalmol 1988:106, pp.192-8]
Selenium is sometimes recommended, but you should always consult your physician to determine appropriate dosages.
Bilberry contains compounds which act as antioxidants in the retina, making it a possible preventive measure for macular degeneration [Klin Monatsbl Augenheilkd Beih 1981;178: pp.386-9]. It also strengthens capillaries in the retina and reduces hemorrhaging [Minerva Med 1977;68: pp.3565-81]. An oral dose is in the range of 40 to 80mg (24% anthocyanosides) per day.
Lutein, an antioxidant found in spinach and kale, works extremely well in protecting the retina against sunlight damage [Methods Enzymol 1992:213: pp.360-6]. Supplementation with 6mg of Lutein daily may decrease the occurrence of macular degeneration by more than 50% [JAMA 1994:272: pp.1413-20]. Lutein is one of the primary antioxidants for the macula rather than for the lens of the eye.
Taking anti-oxidants such as vitamins C and E has beneficial protective effects against age-related macular degeneration (AMD). Since oxidative damage of the eye can cause macular degeneration, taking antioxidants may lower the disease's occurrence. People with high levels of vitamin C, vitamin E and selenium appear to have a 70% lower risk of developing macular degeneration. [Arch Ophthalmol, December 1995:113(12, 15): pp.18-23; Arch Ophthalmol 1993:111: pp.104-9]
Long-term use of multiple antioxidants plus zinc and copper clearly reduced the risk of developing advanced AMD and the rate of visual acuity loss in a randomized, double-blind, placebo-controlled trial of 3,640 older adults (aged 55-80 years) with preexisting retinal abnormalities, advanced AMD or vision loss due to AMD who were followed for an average of 6.3 years. [AREDS Report No. 8. Arch Ophthalmol 2001;119(10): pp.1417-1436]
Your body is a highly complex, interconnected system. Instead of guessing at what might be wrong, let us help you discover what is really going on inside your body based on the many clues it is giving.
Our multiple symptom checker provides in-depth health analysis by The Analyst™ with full explanations, recommendations and (optionally) doctors available for case review and answering your specific questions.